The deep freeze in biotech is beginning to thaw. About half a dozen biotechnology companies have gone public since the start of 2024, with some raising hundreds of millions of dollars. The jump-start ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback